These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23546403)

  • 1. [Response to comment on the article "DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico" by Enrique Bolado-Martínez and collaborators].
    Bolado-Martínez E; Pérez-Mendoza A; Alegría-Morquecho FM; Candia-Plata Mdel C; Aguayo-Verdugo Mdel R; Alvarez-Hernández G
    Salud Publica Mex; 2013 Apr; 55(2):151. PubMed ID: 23546403
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comment on the article "DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico" by Enrique Bolado-Martínez and collaborators].
    Flores-Treviño S; Garza-González E
    Salud Publica Mex; 2013 Apr; 55(2):150-1. PubMed ID: 23546402
    [No Abstract]   [Full Text] [Related]  

  • 3. [DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico].
    Bolado-Martínez E; Pérez-Mendoza A; Alegría-Morquecho FM; Candia-Plata Mdel C; Aguayo-Verdugo Mdel R; Alvarez-Hernández G
    Salud Publica Mex; 2012; 54(2):167-70. PubMed ID: 22535176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on: isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Köser CU; Summers DK; Archer JA
    J Antimicrob Chemother; 2011 Mar; 66(3):686-7; author reply 687. PubMed ID: 21177677
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
    Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
    Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the FluoroType MTBDR Assay for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates.
    Hillemann D; Haasis C; Andres S; Behn T; Kranzer K
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29593055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Valvatne H; Syre H; Kross M; Stavrum R; Ti T; Phyu S; Grewal HM
    J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin resistance in tuberculosis outbreak, London, England.
    Jenkins C
    Emerg Infect Dis; 2005 Jun; 11(6):931-4. PubMed ID: 15963290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
    Aslan G; Tezcan S; Emekdaş G
    Mikrobiyol Bul; 2009 Apr; 43(2):217-26. PubMed ID: 19621606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation.
    Afanas'ev MV; Ikryannikova LN; Il'ina EN; Sidorenko SV; Kuz'min AV; Larionova EE; Smirnova TG; Chernousova LN; Kamaev EY; Skorniakov SN; Kinsht VN; Cherednichenko AG; Govorun VM
    J Antimicrob Chemother; 2007 Jun; 59(6):1057-64. PubMed ID: 17442757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
    Nikolayevsky V; Brown T; Balabanova Y; Ruddy M; Fedorin I; Drobniewski F
    J Clin Microbiol; 2004 Oct; 42(10):4498-502. PubMed ID: 15472300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the Genotype MTBDR assay directly on sputum specimens.
    Hillemann D; Rüsch-Gerdes S; Richter E
    Int J Tuberc Lung Dis; 2006 Sep; 10(9):1057-9. PubMed ID: 16964801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada.
    Bolotin S; Alexander DC; Chedore P; Drews SJ; Jamieson F
    J Antimicrob Chemother; 2009 Aug; 64(2):263-6. PubMed ID: 19520719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates from northeast Mexico.
    Viader-Salvadó JM; Luna-Aguirre CM; Reyes-Ruiz JM; Valdez-Leal R; del Bosque-Moncayo Mde L; Tijerina-Menchaca R; Guerrero-Olazarán M
    Microb Drug Resist; 2003; 9(1):33-8. PubMed ID: 12705681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Mycobacterium tuberculosis resistance mutations to rifampin and isoniazid by real-time PCR.
    Hristea A; Otelea D; Paraschiv S; Macri A; Baicus C; Moldovan O; Tinischi M; Arama V; Streinu-Cercel A
    Indian J Med Microbiol; 2010; 28(3):211-6. PubMed ID: 20644308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam.
    Caws M; Duy PM; Tho DQ; Lan NT; Hoa DV; Farrar J
    J Clin Microbiol; 2006 Jul; 44(7):2333-7. PubMed ID: 16825345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant prevention concentration of isoniazid, rifampicin and rifabutin against Mycobacterium tuberculosis.
    Rodríguez JC; Cebrián L; Ruiz M; López M; Royo G
    Chemotherapy; 2005 May; 51(2-3):76-9. PubMed ID: 15870500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of mutations causing rifampicin and isoniazid resistance of Mycobacterium tuberculosis in Syria.
    Madania A; Habous M; Zarzour H; Ghoury I; Hebbo B
    Pol J Microbiol; 2012; 61(1):23-32. PubMed ID: 22708343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
    Aslan G; Tezcan S; Serin MS; Emekdas G
    Jpn J Infect Dis; 2008 Jul; 61(4):255-60. PubMed ID: 18653964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.